Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: Results from the Treat Asia HIV observational database

• Main Authors: Lim P., Zhou J., Ditangco R., Law M., Sirisanthana T., Kumarasamy N., Chen Y., Phanuphak P., Lee C., Saphonn V., Oka S., Zhang F., Choi J., Pujari S., Kamarulzaman A., Li P., Merati T., Yunihastuti E., Messerschmidt L., Sungkanuparph S.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862780931&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42898
• Institution: Chiang Mai University

Background: Pneumocystis jiroveci pneumonia (PCP) prophylaxis is recommended for patients with CD4 counts of less than 200 cells/mm 3 . This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality....